Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1984-2-20
|
pubmed:abstractText |
Twenty-seven children with Hodgkin's disease were treated with MVOPP (mustine, Velban [vinblastine], Oncovin [vincristine], procarbazine, prednisone) combination chemotherapy. All 11 children with Stage I or Stage II disease achieved complete remission and no relapses have occurred between 34 and 179 months of continuous follow-up. Of the 16 children with Stage III or Stage IV disease, two with partial remission and three nonresponding patients died with a median survival of 18 months. The remaining 11 (68%) achieved complete remission. Of these, 6 (55%) have relapsed with a median remission duration of 36 months; five have been retreated with MVOPP, and one with total nodal irradiation, and all achieved second complete remission. Three of the children have died of Hodgkin's disease, with a median survival of 55 months; one child died of acute myeloblastic leukemia while in remission; and one child remains disease-free off all therapy at 165 months; the sixth child treated with total nodal irradiation is disease-free at 166 months. The initial complete remission has been sustained in all 11 children with Stage I or Stage II Hodgkin's disease, suggesting that combination chemotherapy is an alternative to radiotherapy as the initial form of treatment in this group of individuals.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Mechlorethamine,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Procarbazine,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
210-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6546299-Adolescent,
pubmed-meshheading:6546299-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:6546299-Child,
pubmed-meshheading:6546299-Child, Preschool,
pubmed-meshheading:6546299-Female,
pubmed-meshheading:6546299-Follow-Up Studies,
pubmed-meshheading:6546299-Hodgkin Disease,
pubmed-meshheading:6546299-Humans,
pubmed-meshheading:6546299-Male,
pubmed-meshheading:6546299-Mechlorethamine,
pubmed-meshheading:6546299-Neoplasm Staging,
pubmed-meshheading:6546299-Prednisolone,
pubmed-meshheading:6546299-Procarbazine,
pubmed-meshheading:6546299-Recurrence,
pubmed-meshheading:6546299-South Africa,
pubmed-meshheading:6546299-Vinblastine,
pubmed-meshheading:6546299-Vincristine
|
pubmed:year |
1984
|
pubmed:articleTitle |
Hodgkin's disease in children. A ten-year experience in South Africa.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|